ci 922 has been researched along with mocetinostat in 2 studies
| Studies (ci 922) | Trials (ci 922) | Recent Studies (post-2010) (ci 922) | Studies (mocetinostat) | Trials (mocetinostat) | Recent Studies (post-2010) (mocetinostat) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 21,735 | 390 | 8,606 |
| Protein | Taxonomy | ci 922 (IC50) | mocetinostat (IC50) |
|---|---|---|---|
| Histone deacetylase 3 | Homo sapiens (human) | 0.7851 | |
| Nuclear receptor corepressor 1 | Homo sapiens (human) | 0.022 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.57 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.102 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.102 | |
| Histone deacetylase 4 | Homo sapiens (human) | 0.5717 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.3433 | |
| Histone deacetylase 7 | Homo sapiens (human) | 0.6725 | |
| Histone deacetylase 2 | Homo sapiens (human) | 0.3537 | |
| Histone deacetylase 11 | Homo sapiens (human) | 0.6386 | |
| Histone deacetylase 8 | Homo sapiens (human) | 0.6725 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.5717 | |
| Histone deacetylase 5 | Homo sapiens (human) | 0.6725 | |
| Nuclear receptor corepressor 2 | Homo sapiens (human) | 0.045 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conroy, MC; Hoffman, MD; Thueson, DO; Wright, CD | 1 |
| Abrams, GD; Dysko, RC; Eller, BT; Lucchesi, BR; Shea, MJ; Simpson, PJ; Werns, SW | 1 |
2 other study(ies) available for ci 922 and mocetinostat
| Article | Year |
|---|---|
Inhibition of human neutrophil activation by the allergic mediator release inhibitor, CI-922: differential inhibition of responses to a variety of stimuli.
Topics: Azoles; Cell Movement; Chemotaxis, Leukocyte; Histamine Release; Humans; Hydrogen Peroxide; Indoles; Kinetics; Lysosomes; Muramidase; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxidation-Reduction; Peroxidase; Phosphatidylinositols; Superoxides; Tetrazoles | 1987 |
Protection of reperfused ischemic canine myocardium by CI-922, a new inhibitor of leukocyte activation.
Topics: Animals; Azoles; Coronary Circulation; Dogs; Electrocardiography; Hemodynamics; Indoles; Male; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Peroxidase; Superoxides; Tetrazoles | 1988 |